Marketscreener
Published September 14, 2026
Definium's LSD -based drug lowers anxiety in new late-stage trial, shares soar
Read the full story at Marketscreener
Definium Therapeutics said its LSD -based treatment reduced symptoms of generalized anxiety disorder in a second successful late-stage study,.
Surfaced by 2 Google Alerts
- LSD
- Psychedelic biotech
